← Open Payments lookup

JANINE HYDEN: Open Payments

NPI 1982700464 · HOUSTON, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$910 in 49 payments from 11 companies in 2025. Trend: 2023 $813 · 2024 $822 · 2025 $910

Food & beverage: $910
CompanyPaymentsAmount
Salix Pharmaceuticals, a division of Bausch Health US, LLC21$293
ABBVIE INC.8$140
Madrigal Pharmaceuticals7$113
Takeda Pharmaceuticals U.S.A., Inc.4$98
One Lambda, Inc.1$79
Genentech USA, Inc.2$46
Mirum Pharmaceuticals, Inc.2$37
Baxter Healthcare1$32
La Jolla Pharmaceutical Company1$27
ORPHALAN INC1$24

Products named: XIFAXAN, TEFLARO, REZDIFFRA, LIVTENCITY, Tecentriq, Livmarli, PERCLOT, GIAPREZA.

Industry payments across TX — which companies pay providers there.